glp-1 oral medication for weight loss weight-loss drugs may also curb alcohol cravings Clinically backed oral GLP FDA Approves Oral Semaglutide as

55 An uncontrolled trial found a topical gel containing methylnicotinamide (a form of nicotinamide) applied twice daily for four weeks led to reduced rosacea symptoms in 26 of 34 cases

By serving as an immediate treatment option that reduces addictive drive without precipitating withdrawal symptoms, GLP-1 supported initiation onto buprenorphine and naltrexone may improve success rates by making it easier for patients to reach the short-term withdrawal thresholds required to begin treatment

The lack of robust BPC-157 human trialsspecifically Phase II and Phase III studiesmeans that definitive conclusions about its efficacy, optimal dosing, and long-term safety in humans cannot be made

doi: 10.3389/fnmol.2023.1219574 40

Another patient group who might benefit from treatment with GLP-1R agonists is gastric by-pass patients who increase their alcohol intake after surgery